If there is a dream-team in cyclodextrin research, this author-crew might be the one.
By introducing this standardized nomenclature to the world of cyclodextrins, especially molecular modeling, we aim to enhance molecular design, improve reproducibility, and streamline both experimental and computational research in the CD field.
Special thanks to Angel Piñeiro and Rebeca Garcia-Fandino for the great concept, Amelia Anderson and Matthew “Oki” O’Connor (Cyclarity Therapeutics), J. D. Pipkin (Ligand Pharmaceuticals), Milo Malanga PhD, Milo, Tamas Sohajda (CarboHyde), Thorsteinn Loftsson (Oculis) and Lajos Szente (Cyclolab R&D Ltd.) for contributing.
